Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PTPRZ1-Targeting RNA CAR T Cells Exert Antigen-Specific and Bystander Antitumor Activity in Glioblastoma.
Martinez Bedoya D, Marinari E, Davanture S, Castillo Cantero L, Erraiss S, Dockerill M, Barluenga S, Winssinger N, Schaller K, Bijlenga P, Momjian S, Voize C, Tissot SR, Kandalaft LE, Hammel P, Cosson P, Walker PR, Dutoit V, Migliorini D. Martinez Bedoya D, et al. Among authors: dutoit v. Cancer Immunol Res. 2024 Dec 3;12(12):1718-1735. doi: 10.1158/2326-6066.CIR-23-1094. Cancer Immunol Res. 2024. PMID: 39269445
Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin.
Genoud V, Dutoit V, Thang NT, Janowczyk A, McKee T, Chalandon Y, Tsantoulis P, Dietrich PY. Genoud V, et al. Among authors: dutoit v. Haematologica. 2024 Jul 1;109(7):2364-2367. doi: 10.3324/haematol.2023.284318. Haematologica. 2024. PMID: 38186348 Free PMC article. No abstract available.
Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma.
Bassot A, Dragic H, Haddad SA, Moindrot L, Odouard S, Corlazzoli F, Marinari E, Bomane A, Brassens A, Marteyn A, Hibaoui Y, Petty TJ, Chalabi-Dchar M, Larrouquere L, Zdobnov EM, Legrand N, Tamburini J, Lincet H, Castets M, Yebra M, Migliorini D, Dutoit V, Walker PR, Preynat-Seauve O, Dietrich PY, Cosset É. Bassot A, et al. Among authors: dutoit v. Cell Death Dis. 2023 Sep 25;14(9):630. doi: 10.1038/s41419-023-06117-z. Cell Death Dis. 2023. PMID: 37749143 Free PMC article.
Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer.
Corrò C, Buchs NC, Tihy M, Durham-Faivre A, Bichard P, Frossard JL, Puppa G, McKee T, Roth A, Zilli T, Trembleau C, Di Marco M, Dutoit V, Dietrich PY, Ris F, Koessler T. Corrò C, et al. Among authors: dutoit v. BMC Cancer. 2022 Jul 15;22(1):772. doi: 10.1186/s12885-022-09820-w. BMC Cancer. 2022. PMID: 35840912 Free PMC article.
Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer.
Bordry N, Addeo A, Jaksic C, Dutoit V, Roux-Lombard P, Shah DP, Shah PK, Gayet-Ageron A, Friedlaender A, Bugeia S, Gutknecht G, Battagin A, Di Marco M, Simand PF, Labidi-Galy I, Fertani S, Sandoval J, Dietrich PY, Mach N. Bordry N, et al. Among authors: dutoit v. iScience. 2021 Dec 24;25(1):103699. doi: 10.1016/j.isci.2021.103699. eCollection 2022 Jan 21. iScience. 2021. PMID: 34977496 Free PMC article.
87 results